StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Earnings

Kiora Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 24, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$1.00M
EPS, Q3 FY2026
-$0.28
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Kiora Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026before the open$1.00M–-$0.28Release
Q2 FY2026ended Jun 30, 2026Aug 7, 2026before the open––-$0.34Release
Q1 FY2026ended Mar 31, 2026May 8, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Mar 25, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 7, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 8, 2025before the open–––Release
Q1 FY2025ended Mar 31, 2025May 9, 2025before the open––-$0.52Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 8, 2024before the open––-$0.81Release
Q2 FY2024ended Jun 30, 2024Aug 9, 2024before the open$20.00K–-$0.53Release
Q1 FY2024ended Mar 31, 2024May 10, 2024before the open$16.00M–$0.38Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Kiora Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Kiora Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Kiora Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Update
  5. Update
  6. Results
  7. Update
  8. Results
  9. Update
  10. Update
  11. Results
  12. Results
  13. Update
  14. Results
  15. Update

See a number that looks wrong?